Deborah J Andrews insider trades

Open-market stock purchases and sales by Deborah J Andrews, Chief Financial Officer & EVP at Staar Surgical Co, from SEC Form 4 filings since Mar 5, 2010.

Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +221%.

Recent trades

DateStockTradeValue
Aug 14, 2026STAA Staar Surgical CoBought (not open market)—
Aug 14, 2026STAA Staar Surgical CoBought (not open market)—
Aug 14, 2026STAA Staar Surgical CoSold (not open market)$69.7K
Aug 14, 2026STAA Staar Surgical CoBought (not open market)—
Aug 14, 2026STAA Staar Surgical CoBought (not open market)—
Jul 31, 2026STAA Staar Surgical CoSold (not open market)$258K
Jul 31, 2026STAA Staar Surgical CoBought (not open market)—
Jun 25, 2026STAA Staar Surgical CoSold (not open market)$202K
Jun 25, 2026STAA Staar Surgical CoBought (not open market)—
May 15, 2026STAA Staar Surgical CoBought (not open market)—
May 15, 2026STAA Staar Surgical CoSold (not open market)$60.2K
May 15, 2026STAA Staar Surgical CoSold (not open market)$120K
May 15, 2026STAA Staar Surgical CoBought (not open market)—
May 15, 2026STAA Staar Surgical CoBought (not open market)—
May 15, 2026STAA Staar Surgical CoBought (not open market)—
Mar 13, 2026STAA Staar Surgical CoBought (not open market)—
Feb 2, 2026STAA Staar Surgical CoBought (not open market)—

Companies traded

  • STAA Staar Surgical Co: 39 sales, last Aug 14, 2026
  • LCTX Lineage Cell Therapeutics, Inc: 1 sale, last Jul 1, 2025
  • BTX Biotime Inc: 5 buys, last Jul 1, 2019

Get free alerts when Deborah J Andrews files a new trade →